Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.
about
The role of FLT3 in haematopoietic malignanciesStructural and functional alterations of FLT3 in acute myeloid leukemiaPrevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupDownstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implicationsHow I treat pediatric acute myeloid leukemiaFLT3 mutations in acute myeloid leukemia: what is the best approach in 2013?Targeting the TAM Receptors in LeukemiaPrognostic implications of the presence of FLT3 mutations in patients with acute myeloid leukemiaMutant FLT3 signaling contributes to a block in myeloid differentiationPrognostic significance of FLT3-ITD in pediatric acute myeloid leukemia: a meta-analysis of cohort studies.Prenatal origin of childhood AML occurs less frequently than in childhood ALL.Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53.Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AMLFunctional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP).Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.FLT3 Internal Tandem Duplication and D835 Mutations in Patients with Acute Lymphoblastic Leukemia and its Clinical SignificanceThe Cytokine Flt3-Ligand in Normal and Malignant HematopoiesisAcute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Children's Oncology Group.High transcript level of FLT3 associated with high risk of relapse in pediatric acute myeloid leukemia.Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.Lestaurtinib, a multitargeted tyrosine kinase inhibitor: from bench to bedside.High-resolution melting curve analysis, a rapid and affordable method for mutation analysis in childhood acute myeloid leukemiaFunctional integration of acute myeloid leukemia into the vascular niche.The Biology and Targeting of FLT3 in Pediatric Leukemia.Impact of numerical variation in FMS-like tyrosine kinase receptor 3 internal tandem duplications on clinical outcome in normal karyotype acute myelogenous leukemia.FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasmMDM4 overexpressed in acute myeloid leukemia patients with complex karyotype and wild-type TP53The Future of Targeting FLT3 Activation in AML.Class III receptor tyrosine kinases: role in leukaemogenesis.Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimens.Functional pathway analysis using SCNP of FLT3 receptor pathway deregulation in AML provides prognostic information independent from mutational statusReceptor tyrosine kinase mutations in myeloid neoplasms.Genetic profile of acute myeloid leukemia.FLT3 in human hematologic malignancies.Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.Further activation of FLT3 mutants by FLT3 ligandFlt3 mutations and leukaemia.Novel agents for the treatment of childhood acute leukemia.FLT3: ITDoes matter in leukemia.Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia
P2860
Q24319174-9F6687A3-A99F-4A98-9F63-19498B1F37E8Q24338964-2B98D4D9-4628-4B7E-BF14-9D5423D6AEBEQ24602856-390EC0DD-D615-4CFF-B73A-BE78268A2D27Q24617091-CF0F85C1-F1B0-4C0D-818F-5A4836D74697Q26992280-0EBD484F-CA3D-4C47-B0C6-2175FD9E1BCDQ27028163-2DD769D1-8A39-45E6-B6E2-C0CE229943DCQ28078654-8478FE52-D4A8-4ADA-9712-FD57B870D1D3Q28186429-7039EDCF-DEE1-47AD-BDE9-CF21FD2CE0FFQ28279890-F998EA06-382B-4321-A27F-218986010780Q30248904-69A556F5-D02F-44D0-8F1C-F1883368597EQ33240663-9C23C33F-374D-49C8-9A4D-1B3C89F9DFD7Q33397876-C193F1AB-8CBE-4CA0-882B-379157DD134BQ33702150-9F588C61-5F7B-4853-B732-5F1CAE9CC0B3Q33737486-D83CE823-147D-4084-AD2F-5A729BD469DFQ33754603-B8C10E20-3F16-47D6-BCF7-44CD91460825Q33778374-93C32DC1-D0E4-4C18-9FE2-128E9116F049Q33838356-9D92DC8F-E198-4B42-BD24-668A28E27A03Q33838668-AE4E09EB-F55E-462A-AA4F-32C2015C9985Q33879678-EB590733-71B6-48DD-A387-1023AD4F987AQ34052581-16312FB5-F1EA-47FA-9E8E-46C45C19E334Q34097586-AFAE40DB-A811-4A83-9972-EEF15CBE5C3CQ34154213-016624C8-334B-469F-861C-AF2D3B88E892Q34207361-E3C0AEF1-92E2-4EBB-8EE4-73C973CF0BEFQ34229555-1C4EBA17-1811-4D94-ACB6-BF61C437F172Q34285896-364F5ED6-0147-4873-9A48-32C613E6337CQ34408941-E1BBB056-19E5-4EF0-ACD1-D51F02520F82Q34535844-5EA9E926-32CC-49A0-B743-011710633F07Q34555386-87735275-28C6-4167-A564-E3E17F6C1C6FQ34557003-A97F717D-0315-4BA0-97F0-5150DBE2B34EQ34591403-B6275671-918A-4CF8-851F-4CB611AC7D0BQ34595162-229CB573-18F1-4F79-A9ED-9E45174CD868Q34655403-B9439F7E-5569-4958-BF0B-2D04E2486E45Q34680927-388AAF63-A8C6-4247-A803-D684FAEAEE30Q34980355-6CDA1130-91A7-463B-960C-CA62852BF224Q35134983-6C91A9EF-F9E8-4979-8164-5916E5212BDBQ35163307-D24DE51D-C6C2-4DF9-BCF8-B3A50211145BQ35192266-0E2A22CC-F96C-4E99-AE66-2A1A5526F7FAQ35192790-B6216C6F-F6A8-4CF4-88B8-C567AD7C4E6DQ35217399-16E9D8CE-A5D6-4B51-9F94-6D56BBD66EBCQ35265916-22D3D55E-794E-4D83-A127-BED4735DF073
P2860
Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Prevalence and prognostic sign ...... iatric acute myeloid leukemia.
@ast
Prevalence and prognostic sign ...... iatric acute myeloid leukemia.
@en
type
label
Prevalence and prognostic sign ...... iatric acute myeloid leukemia.
@ast
Prevalence and prognostic sign ...... iatric acute myeloid leukemia.
@en
prefLabel
Prevalence and prognostic sign ...... iatric acute myeloid leukemia.
@ast
Prevalence and prognostic sign ...... iatric acute myeloid leukemia.
@en
P2093
P356
P1433
P1476
Prevalence and prognostic sign ...... iatric acute myeloid leukemia.
@en
P2093
Bernstein ID
Buckley JD
Meshinchi S
Stirewalt DL
Sweetser DA
P356
10.1182/BLOOD.V97.1.89
P407
P577
2001-01-01T00:00:00Z